Chimeric antigen receptor T (CAR‐T) cells: Novel cell therapy for hematological malignancies

Over the last decade, the emergence of several novel therapeutic approaches has changed the therapeutic perspective of human malignancies. Adoptive immunotherapy through chimeric antigen receptor T cell (CAR‐T), which includes the engineering of T cells to recognize tumor‐specific membrane antigens...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbasi, Samane, Totmaj, Milad Asghari, Abbasi, Masoumeh, Hajazimian, Saba, Goleij, Pouya, Behroozi, Javad, Shademan, Behrouz, Isazadeh, Alireza, Baradaran, Behzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
REVIEWS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134288/
https://www.ncbi.nlm.nih.gov/pubmed/36583504
http://dx.doi.org/10.1002/cam4.5551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134288/
https://www.ncbi.nlm.nih.gov/pubmed/36583504
http://dx.doi.org/10.1002/cam4.5551

Ejemplares similares